Case Report: Anti-neutrophil Cytoplasmic Antibody-Associated Vasculitis With Acute Renal Failure and Pulmonary Hemorrhage May Occur After COVID-19 VaccinationMedicine Published on 2021-11-112022-10-31 Journal: Frontiers in Medicine [Category] COVID-19, [키워드] acute renal failure administration anti-CD20 therapy anti-neutrophil cytoplasmic antibody (ANCA) antibody coronavirus disease COVID-19 COVID-19 mRNA Vaccination COVID-19 vaccination cytoplasmic failure first dose gross hematuria hemoptysis increase in instance management Moderna nasopharyngeal plasma polymerase chain pulmonary pulmonary hemorrhage pulmonary renal syndrome renal renal biopsy renal function resolved resulting RNA virus serum serum creatinine severe adverse effect susceptible patient syndrome Systemic steroid Urinalysis vaccination Vasculitis [DOI] 10.3389/fmed.2021.765447 PMC 바로가기 [Article Type] Medicine
ANCA vasculitis: A manifestation of Post-Covid-19 SyndromeCase Report Published on 2021-11-112022-10-29 Journal: Respiratory Medicine Case Reports [Category] COVID-19, [키워드] acute renal failure ANCA-associated vasculitis antibody bleeding Cardiac arrest Coagulopathy Complication complication of COVID-19 complications consolidation COVID-19 COVID-19 infection CRP Culture definitive diagnosis develop elevated erythrocytes healthy Hemodialysis hemoptysis highlight Hospitalization Infection Inflammation initial initiated intubation kidney lesion lung male Mild novel patchy Patient positive Protein pulmonary infiltrates renal renal medicine Respiratory medicine SARS-COV-2 infection SARS-CoV-2 virus sustained syndrome tested the patient unique Urinalysis Vasculitis worsened yeast [DOI] 10.1016/j.rmcr.2021.101549 PMC 바로가기 [Article Type] Case Report
A Unique Presentation of Acute Kidney Injury With COVID-19Internal Medicine Published on 2021-11-082022-10-31 Journal: Cureus [Category] COVID-19, [키워드] Acute kidney injury acute renal failure Affect Case report clinical feature clinical manifestation COVID 19 COVID-19 creatinine diagnosis of COVID-19 disease distress Hemodialysis incidence Initially Injury Intensive intensive care intensive care unit morbidity Mortality multifactorial organ Pathogenesis Patient Pneumonia presentation Prevalence reduce renal renal dysfunction reported Respiratory system SARS CoV-2 Supportive treatment the patient unique while [DOI] 10.7759/cureus.19381 PMC 바로가기 [Article Type] Internal Medicine
In-hospital COVID-19 infection echocardiographic analysis: a Brazilian, tertiary single-centre experienceResearch Published on 2021-10-232022-10-31 Journal: Cardiovascular Ultrasound [Category] COVID-19, MERS, SARS, [키워드] acute renal failure Analysis AUC Biomarkers Brazil clinical information composite endpoint concerning consecutive patient correlated COVID-19 COVID-19 infection death diastolic dysfunction echocardiographic echocardiographic finding echocardiographic parameter echocardiography Ejection fraction evaluated events Haemodialysis Hospitalized hospitalized patient In-hospital mechanical ventilation men Mortality Mortality, pulmonary thromboembolism Myocardial infarction occurred Patient patients predict renal renal failure required Result ROC thoracic tomography Thromboembolism was related with COVID-19 [DOI] 10.1186/s12947-021-00265-y PMC 바로가기 [Article Type] Research
Endothelial Activation and Stress Index (EASIX) as an Early Predictor for Mortality and Overall Survival in Hematological and Non-Hematological Patients with COVID-19: Multicenter Cohort StudyArticle Published on 2021-09-242022-10-30 Journal: Journal of Clinical Medicine [Category] COVID-19, [키워드] Activation acute renal failure Admission Biomarker Cancer Cancer patients characterized Course COVID-19 COVID-19 diagnosis COVID-19 patient COVID-19 patients creatinine demonstrated disease EASIX endothelial Endothelial dysfunction Endothelium group hematological hematological cancer Hematological malignancy Hemodialysis high mortality rate hospitalized COVID-19 patient hospitalized patients in-hospital mortality index intensive care lactate dehydrogenase multiple organs Occurrence Patient patients patients with COVID-19 performed Platelet count prognostic Retrospective analysis risk Sepsis significantly Stress survival with COVID-19 [DOI] 10.3390/jcm10194373 PMC 바로가기 [Article Type] Article
Negative effects of iodine-based contrast agent on renal function in patients with moderate reduced renal function hospitalized for COVID-19Research Published on 2021-08-312022-10-28 Journal: BMC Nephrology [Category] COVID-19, MERS, [키워드] 30-Day mortality acute renal failure administration Affect Analysis Computed tomography contrast agent Contrast-induced acute renal failure COVID COVID − 19 COVID-19 creatinine death defined disease Effect evaluated Factor FIVE Follow-up Frequency glomerular filtration rate group hospital Hospitalized indication Iodinated contrast negative not differ P-creatinine Patient patients patients died patients with moderate Pearson reduced renal renal function renal replacement therapy Result was measured [DOI] 10.1186/s12882-021-02469-w PMC 바로가기 [Article Type] Research
Antibiotic Use and Fatal Outcomes among Critically Ill Patients with COVID-19 in Tacna, PeruArticle Published on 2021-08-092022-10-27 Journal: Antibiotics [Category] COVID-19, [키워드] Acinetobacter acute renal failure Adjusted analysis Anti-bacterial agents Antibiotics aRR Bacteria Bacterial Characteristics Complication conducted COVID-19 Critical Critically ill patient critically ill patients Cross-infection death Dexamethasone died drug resistance evaluate evolution of patients Follow-up HAI healthcare hospital Hospital mortality ICU ICU admission Ill incidence increased risk Infection infections intensive care IQR Isolation median Mortality occurred organism pandemic pathogen Patient patients evaluated patients with COVID-19 Peru proportion Pseudomonas aeruginosa required retrospective cohort study SARS-CoV-2 significantly with COVID-19 [DOI] 10.3390/antibiotics10080959 PMC 바로가기 [Article Type] Article
A randomized open-label trial to evaluate the efficacy and safety of triple therapy with aspirin, atorvastatin, and nicorandil in hospitalised patients with SARS Cov-2 infection: A structured summary of a study protocol for a randomized controlled trialSARS Cov-2 감염으로 입원한 환자에서 아스피린, 아토르바스타틴, 니코란딜을 사용한 삼중 요법의 효능과 안전성을 평가하기 위한 무작위 공개 시험: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약Letter Published on 2021-07-152022-09-10 Journal: Trials [Category] SARS, 임상, [키워드] 1:1 ACHE Acute coronary syndrome Acute kidney injury acute renal failure adequate hydration adjuvant therapy Admission allergy ALT/AST Altered mental status Anti-inflammatory anticoagulation antipyretics Antithrombotic approved ARDS Aspirin AST/ALT atorvastatin bleeding Blinding block randomization Breastfeeding brown urine change characterized clinical clinical feature Clinical features Coagulopathy college Combination comorbid condition comorbid conditions comparator conducted control group coronary syndrome Corticosteroid Corticosteroids cough COVID-19 CPK creatine creatine kinase creatinine CRP current therapy Dexamethasone dissemination dose drug dysfunction Dyspnoea dysregulation effective Efficacy and safety element Endothelial dysfunction enrolled ethical committee evaluate excluded ferritin Fever followed by greater heparin hepatotoxicity Hospital admission hospital discharge Hospital mortality Hospital stay hospitalised patient Hospitalised patients hyperbilirubinemia hypoxia ICMR IEC immune dysregulation immunomodulatory impaired consciousness in-hospital mortality India Inflammation Inflammatory marker inflammatory markers Intervention intervention group intolerance intravenous Intravenous remdesivir invasive limit liver low molecular weight low molecular weight heparin management marker mechanical ventilation medication medications moderate muscle ache myalgia Myoglobin Myopathy myositis national guidelines Nicorandil Non-invasive number objective once daily Open-label open-label trial outcome oxygen Oxygen requirement oxygen support participant pathophysiologic pathophysiology Patient Platelet Platelet count Pneumonia positive Pregnancy Primary outcome progression protocol raised Rajendra Prasad Randomised control trial randomization randomize Randomized Randomized controlled trial randomly divided receive recruitment reducing mortality Registered registry Remdesivir renal failure reported respiratory rate rhabdomyolysis room air RT-PCR safety endpoint safety endpoints Sample size SARS-CoV-2 infected patient SARS-COV-2 infection Schematic screened Secondary outcomes Sepsis serum serum markers severe disease Shock significant interaction SpO2 Standard Standard of care starting dose statin statins Study design Study protocol substrates supplementary material Symptom Symptomatic treatment Tablet therapeutic therapeutic agent therapy thrombocytopenia Treatment Trial Trial registration two-arm parallel ULN Urine weakness website [DOI] 10.1186/s13063-021-05361-y PMC 바로가기 [Article Type] Letter
Different incidences of acute kidney injury (AKI) and outcomes in COVID-19 patients with and without non-azithromycin antibiotics: A retrospective study비 아지스로마이신 항생제를 사용하거나 사용하지 않는 COVID-19 환자의 급성 신장 손상(AKI) 발생률 및 결과: 후향적 연구Article Published on 2021-07-012022-09-11 Journal: Journal of medical virology [Category] SARS, 치료제, [키워드] 2019-nCoV 95% confidence interval acute kidney Acute kidney injury acute renal failure addition administration Admission Adult patients adverse events AKI angiotensin Angiotensin II angiotensin-converting enzyme inhibitor angiotensin-converting enzyme inhibitors Antibiotics association blockers caused Comorbidities Comorbidity concomitant infection conducted coronavirus disease Coronavirus disease 2019 Corticosteroid Corticosteroids COVID-19 COVID-19 patient criteria death determine diabete diabetes Effect evaluate the effect help Hospitalization hypertension ICU ICU admission incidence incidence rate indication indications initiated intensive care intensive care unit Kidney injury Lopinavir Lopinavir/ritonavir medication medications Mortality multivariable logistic regression nCoV Novel coronavirus Odds ratio outbreak outcome outcomes Participants Patient patients patients hospitalized poor prognosis Predictive Primary outcome receptor renal renal failure Retrospective study ribavirin Ritonavir SARS-CoV-2 secondary outcome severity was used with COVID-19 [DOI] 10.1002/jmv.26992 PMC 바로가기 [Article Type] Article
Chronic anticoagulation is not associated with a reduced risk of acute kidney injury in hospitalised Covid-19 patientsResearch Published on 2021-06-162022-10-28 Journal: BMC Nephrology [Category] COVID-19, MERS, SARS, [키워드] Acute kidney injury acute renal failure Admission AKI Anticoagulant anticoagulant therapy anticoagulation chronic COVID-19 criteria determine diagnosis of COVID-19 disease Factor foundation global pandemic group hospitalised hypercoagulable hypertension incidence intensive care unit KDIGO Kidney disease less Male sex mechanical ventilation Mortality no difference occur outcome Patient patients with COVID-19 randomised controlled study receive reduced reduced risk renal renal replacement therapy Respiratory failure Result SARS-CoV2 severity supplementary material therapy thrombosis thrombotic Treatment Trust university unlikely were excluded World Health Organisation [DOI] 10.1186/s12882-021-02436-5 PMC 바로가기 [Article Type] Research